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Abstract
Background:  The human POB1/REPS2 (Partner of RalBP1) protein is highly conserved in
mammals where it has been suggested to function as a molecular scaffold recruiting proteins
involved in vesicular traffic and linking them to the actin cytoskeleton remodeling machinery. More
recently POB1/REPS2 was found highly expressed in androgen-dependent prostate cancer cell
lines, while one of its isoforms (isoform 2) is down regulated during prostate cancer progression.
Results: In this report we characterize the central proline rich domain of POB1/REPS2 and we
describe for the first time its functional role in receptor endocytosis. We show that the ectopic
expression of this domain has a dominant negative effect on the endocytosis of activated epidermal
growth factor receptor (EGFR) while leaving transferrin receptor endocytosis unaffected. By a
combination of different approaches (phage display, bioinformatics predictions, peptide arrays,
mutagenic analysis, in vivo co-immunoprecipitation), we have identified two closely spaced binding
motifs for 14-3-3 and for the SH3 of the proteins Amphiphysin II and Grb2. Differently from wild
type, proline rich domains that are altered in these motifs do not inhibit EGFR endocytosis,
suggesting that these binding motifs play a functional role in this process.
Conclusion:  Our findings are relevant to the characterization of the molecular mechanism
underlying the involvement of POB1/REPS2, SH3 and 14-3-3 proteins in receptor endocytosis,
suggesting that 14-3-3 could work by bridging the EGF receptor and the scaffold protein POB1/
REPS2.
Background
POB1/REPS2 (from now on POB1) was initially identi-
fied in a yeast two-hybrid screening as a partner of RalBP1
[1], an effector of the small G protein Ral [2] that displays
a GAP activity towards Rac1 and Cdc42 [3]. POB1 is
expressed as two isoforms, the short isoform is 521 resi-
dues long while the second one differs due to its having a
139 amino acid extension at the amino-terminus. The
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most prominent structural/functional features, which are
common to both isoforms, include an amino-terminal
EH (Eps15 Homology) domain, a central region contain-
ing two adjacent proline-rich regions and a carboxy-termi-
nal portion mediating the binding to RalBP1. Via its EH
domain, POB1 associates with Eps15 and Epsin [4,5].
The observed interactions with proteins involved in the
endocytic pathway and the report that over-expression of
the EH domain or the RalBP1 binding region inhibits EGF
and insulin internalization, implicates POB1 in receptor
endocytosis [4]. Accordingly, POB1 is tyrosine-phosphor-
ylated in response to EGF in COS cells and co-purifies
with activated EGF receptor [1]. Furthermore POB1 co-
immunoprecipitates with over expressed Grb2 (growth
factor receptor-bound protein 2) and with PAG2
(DDEF1), a paxillin-associated protein, at endogenous
levels. The sequence responsible for this latter interaction
was mapped to a proline-rich motif (423PSKPIR428) that
binds to the SH3 domain of PAG2 [6].
Because of its links to receptor endocytosis and to actin
cytoskeleton remodeling, POB1 has been proposed as a
molecular scaffold recruiting proteins involved in vesicu-
lar trafficking and linking them to actin cytoskeleton.
In addition, more recently, it has been reported that loss
of POB1 expression in prostate cancer cells results in
deregulation of growth factor signaling, while an increase
of POB1 expression has been correlated with silencing of
EGF signaling. Moreover, POB1 isoform 2 down-regula-
tion has been observed during progression of prostate
cancer from androgen to EGF dependency [7-9].
Although this scattered information suggest a central role
of POB1 in the complex regulatory mechanisms modulat-
ing growth factor response, no simple model has been put
forward to explain all the observations.
In this work, we show that, in addition to the amino-ter-
minal EH domain and the carboxy-terminal RALBP1
binding region, a third central area of POB1, containing
motifs recognized by the SH3 domains of Grb2 and
Amphiphysin II and by the 14-3-3 family proteins, plays a
role in modulating receptor endocytosis. Over-expression
of this POB1 fragment negatively affects epidermal
growth factor receptor endocytosis by titration and delo-
calization of essential components. Conversely, point
mutations in the conserved binding motifs eliminate the
dominant negative effect on receptor endocytosis. These
data provide support for a role of POB1 as a regulator of
growth factor receptor endocytosis and corroborate its
suggested role as a tumor suppressor.
Results
Expression of the POB1 proline rich region from Pro308 to 
Vel365 inhibits EGFR endocytosis
While expression of full-length POB1 in A431 cells does
not affect either binding or internalization of EGF, over-
expression of either the EH domain or the C-terminal
region of POB1 affects the ligand dependent internaliza-
tion pathway of EGF and insulin without interfering with
the constitutive transferrin pathway [4]. We were inter-
ested in assessing whether the POB1 proline-rich region
plays an additional role in the ligand-dependent endocy-
tosis of EGFR. To this end, we transiently transfected HeLa
cells with green fluorescent protein (GFP) fusion con-
structs expressing either the POB1 isoform 2 full length or
PRD1, the POB1 proline rich region from Pro308 to
Val365 (Fig. 1). As controls we performed parallel trans-
fections with two plasmids expressing GFP or GFP-
Dynamin K44A, a dynamin mutant that is an established
inhibitor of both EGF and transferrin endocytosis [10].
Transfected cells were serum starved and subsequently
incubated with TRITC labeled EGF or transferrin to mon-
itor the two internalization pathways. As already reported,
the ectopic expression of full length POB1 had no influ-
ence on transferrin or EGF endocytosis [4]. Similarly,
POB1 PRD1, the construct expressing a POB1 fragment
from amino acid 308 to 365, did not affect the constitu-
tive transferrin endocytic pathway. On the other hand,
HeLa cells over-expressing the POB1 PRD1, when treated
with TRITC-EGF, have a much reduced number of inter-
nalized EGF-stained vesicles and show a diffuse fluores-
cence, resembling Dynamin K44A expression, indicating
that POB1-PRD1 over-expression interferes with EGF
endocytosis, (Fig. 1, first row). This phenotype has been
observed in five independent experiments with a pene-
trance of 65% of transfected cells. In similar control exper-
iments, over-expression of Dynamin K44A mutant
inhibited EGF internalization with a penetrance of 75%.
The C-terminal SH3 domain of Grb2 and the SH3 domain 
of Amphiphysin II bind to full-length POB1 and to POB1 
PRD1 (308–365)
To further characterize the interaction network centered
on POB1, we sought to isolate proteins binding the pro-
line-rich core region. The POB1 central region from
Pro308 to Val365 was expressed in bacteria as a GST
fusion protein (GST-POB1 PRD1), immobilized on glu-
tathione-sepharose and used as a bait for affinity selection
of a human brain cDNA library displayed on lambda
phage [11]. The selected phage clones were sequenced and
shown to encode either the Src homology 3 domain
(SH3) of Amphiphysin II or the carboxy-terminal SH3
domain of the molecular adaptor Grb2, which was for-
merly shown to bind tagged POB1 in a GST pull-down
assay [1].BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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Expression of the proline rich region of POB1 has a dominant negative effect on EGF endocytosis but it does not affect trans- ferrin endocytosis Figure 1
Expression of the proline rich region of POB1 has a dominant negative effect on EGF endocytosis but it does 
not affect transferrin endocytosis. HeLa cells were transiently transfected with GFP-POB1 PRD1 (308–365) or GFP-POB1 
full length or, as controls, GFP-Dynamin K44A or GFP alone. Cells were serum starved and incubated with TRITC labeled EGF 
for 20 minutes at 37°C. Cells were fixed, without acid wash, and observed on an Olympus IX 70 with Nanomover® and soft-
WoRx Delta Vision. Transfected cells are visible in the 528 nm channel as green colored. TRITC-EGF was visualized at 617 nm 
and is colored in red. Endocytosed vescicles with TRITC-EGF, visible as fluorescent spots, are not detectable in cells over 
expressing the mutated Dynamin K44A or the central proline rich region of POB1 (POB1 PRD1). A black arrow points the 
transfected cells in the zoomed sections. HeLa cells transfected with GFP-POB1 PRD1 (308–365) were serum starved and 
incubated with TRITC-Transferrin (100 mg/ml). POB1-PRD1 transfected cells are visualized as above, internalized transferrin is 
visible as fluorescent red spots.BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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A) The SH3 domain of Amphiphysin II and the carboxy-terminal SH3 of Grb2 bind full length POB1 in pull down experiments Figure 2
A) The SH3 domain of Amphiphysin II and the carboxy-terminal SH3 of Grb2 bind full length POB1 in pull 
down experiments. Lysates of 293 human embryonic kidney cells (HEK293), transiently transfected with POB1-Myc, were 
incubated with GST-SH3 of Amphiphysin II (AmphIISH3), GST-SH3 ammino-terminal of Grb2 (Grb2SH3-N), GST-SH3 car-
boxy-terminal of Grb2 (Grb2SH3-C) and GST alone, adsorbed to glutathione-Sepharose 4B beads. The retained proteins were 
separated by SDS-PAGE and probed with an anti-Myc antibody (for POB1). The input is 10% of the affinity-selected lysate. The 
AmphiphysinII SH3 binds 25% of the input while the carboxy-terminal SH3 of Grb2 binds 4%. The ammino-terminal SH3 of 
Grb2 does not bind POB1. The Ponceau staining shows the GST fusions and the input lysates. B) The SH3 interacting 
motif of POB1 is contained in the 308–365 region. HEK293 cells were transiently transfected with the indicated POB1 
constructs expressed as fusions to GFP protein: GFP (lanes 1, 2, 3), GFP-POB1 full length (lanes 4, 5, 6) and GFP-PRD1, the 
poly-proline rich PRD1 region of POB1 from residue 308 to 365 (7, 8, 9). Cellular extracts were incubated with GST-SH3 of 
AmphiphysinII (left) or GST-SH3 carboxy-terminal of Grb2 (right) and GST alone. The retained proteins were subjected to 
SDS-PAGE and probed with an anti-GFP antibody (for POB1 or PRD1). The sample loaded in the input lane is 5% of the mate-
rial used for affinity selection. A faint unspecific band is visible between the POB1 full length and the PRD1. POB1 PRD1 (308–
365) is bound by both the SH3 tested: Amphiphysin II (last lane in leftmost gel) and Grb2 (last lane in rightmost gel). The Pon-
ceau staining shows the GST fusions and the input lysates. C) POB1 full length co-immunoprecipitates with full length 
Amphiphysin II and endogenous Grb2. Left: POB1-GFP was co-expressed in HEK293 cells together with Grb2-HA or 
Amphiphysin II-FLAG (Amph-FLAG). Cellular extracts were immunoprecipitated (IP) with anti-HA antibody (for Grb2) or anti-
FLAG resin (for Amphiphysin II), respectively and the co-immunoprecipitated POB1 was revealed with an anti-GFP antibody. 
Two lanes for each immuno-precipitation correspond to the same experiment repeated twice but at different washing strin-
gency (without or with 1% Triton). Mock HA and FLAG lanes represent controls transfected with empty vectors. In the input 
lane we have loaded 1.5% of the cell lysate used for the immunoprecipitation. Right: An empty vector (lane 1) and two inde-
pendent transfections of POB1-Myc were carried out in HEK293 cells (lanes 2, 3). Upper panel: POB1-Myc in cell lysate was 
revealed with an anti-Myc antibody (5% of the total cell lysate). Second panel: Cells extracts were immunoprecipitated with 
anti-Myc (for POB1) and the immunoprecipitated POB1 (an amount corresponding to 20% of the total lysate) were revealed 
with an anti-Myc antibody; Third panel: the cell lysate was probed with anti-Grb2 antibody, to detect endogenous Grb2 (1% of 
the total lysate). Panel below: Cells extracts were immunoprecipitated (IP) with anti-Myc (for POB1) and the co-precipitated 
material was blotted (WB) with an anti-Grb2 antibody to detect endogenous Grb2 co-immunoprecipitated by POB1.BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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To support these findings, we prepared a cell extract from
HEK293 cells transfected with a plasmid encoding Myc-
tagged POB1. The extract was incubated with the two SH3
domains of Grb2 (amino- or carboxy-terminal) or the one
of Amphiphysin II, expressed as GST fusion proteins. The
proteins retained by the affinity resin were separated by
SDS-PAGE and probed with an anti-Myc antibody (Fig.
2A). Full length POB1 was only bound by the Grb2 car-
boxy-terminal SH3 or by the Amphiphysin II SH3
domain, whereas the amino-terminal SH3 domain of
Grb2 did not retain the Myc tagged POB1. In a similar
experiment the SH3 domains of Grb2 and Amphiphysin
II were able to bind to the full length POB1 and to the pro-
line rich domain, PRD1 region 308–365, of POB1,
expressed as GFP fusion proteins in HEK293 cells (Fig.
2B).
POB1 co-immunoprecipitates in vivo with Amphiphysin II 
and Grb2
In order to assess whether the interactions between POB1
and Amphiphysin II or Grb2 can take place in vivo, we
transiently co-transfected HEK293 cells with POB1 fused
to GFP, together with either Amphiphysin II-FLAG or
Grb2-HA (Fig. 2C, left panel). Cell lysates were immuno-
precipitated with anti-HA (for Grb2) or anti-FLAG (for
Amphiphysin II) and the immunoprecipitates were
revealed with an anti-GFP antibody (for POB1). While
POB1 co-immunoprecipitates with both Amphiphysin II
and Grb2, none of the control lanes shows any detectable
POB1 immunoprecipitation.
Moreover, ectopically expressed POB1-Myc was also
found to co-immunoprecipitate endogenous Grb2 in
HEK293 cells (Fig. 2C right, lower panel). The co-immu-
noprecipitation of endogenous POB1 full length and
endogenous Grb2 is also detected in HeLa cells in an EGF
independent manner (Additional file 1).
The interaction of POB1 with Amphiphysin II is consist-
ent with the co-localization of POB1 with clathrin, since
Amphiphysin II is a clathrin ligand [12] (Additional file
2). The localization of POB1 in HeLa cells is also not
influenced by EGF addition (Additional file 2).
Arg344 is an important binding determinant in the motifs 
recognized by the SH3 domains of Amphiphysin II and 
Grb2
To identify the recognition motifs bound by the Grb2 and
the Amphiphysin II SH3 domains, we first synthesized, on
a cellulose membrane, sixteen overlapping peptides (13
amino acid long), spanning the POB1-PRD1 sequence
from residue Pro308 to Val365 (Fig. 3A) [13]. The pep-
tides were then probed with the purified SH3 domains of
Amphiphysin II and Grb2, fused to GST. This approach
established the sequence 338PPTPPPRP345 as the one bind-
ing with the highest affinity both SH3 domains (Fig. 3A
and additional file 3, for quantitative analysis). Another
peptide containing the sequence LKARPS binds to the
SH3 of Amphiphysin II, albeit producing a spot intensity
30% lower than the best binder. Next, we systematically
mutagenized the pentadecapeptide
338PPTPPPRPQKTHSRA352, containing the best binding
motif as established above, by replacing each residue with
an alanine (Fig. 3B and additional file 4). This approach
identified Arg344 as the main binding determinant for
both SH3 domains. Interestingly, aside from this com-
mon main determinant, the binding of the Amphiphysin
II SH3 domain is more sensitive to substitutions in
Pro339 while the binding of the SH3 domain of Grb2 is
affected by substitutions in Pro342 and Pro345. This sug-
gests that the two domains bind the same sequence but in
a different mode. To validate Arg344's essential role in the
interaction between POB1 and the SH3 domains of
Amphiphysin II and Grb2, we constructed a variant of the
GFP-PRD1, encoding a PRD1 fragment in which Ala
replaces Arg344 (Fig. 3C). This POB1 construct was tran-
siently transfected into HEK293 cells and cell lysates were
incubated with GST-Amphiphysin II SH3 or GST-Grb2
carboxy-terminal SH3. As shown in Fig. 3C, the
Amphiphysin II SH3 domain binds both to GFP-PRD1
and to GFP-PRD1 R344A. However, the recovery of GFP-
PRD1 R344A is less efficient, confirming that the muta-
tion Arg344Ala affects this interaction. The Grb2 carboxy-
terminal SH3 domain, on the other hand, does not bind
GFP-POB1 PRD1 Arg344Ala at all.
These results map the target of the SH3 domain of
Amphiphysin and the carboxy-terminal SH3 of Grb2 to a
short peptide flanking Arg344 in POB1.
Endogenous 14-3-3 isoforms bind to the POB1 PRD1 
region in a phosphorylation dependent manner
Upon sequence examination by ELM (Eukaryotic Linear
Motif) search, POB1 contains three putative 14-3-3 bind-
ing sites centered on Ser121, Ser322 and Ser354 http://
elm.eu.org. In order to validate this prediction, we per-
formed pull-down experiments using, as baits, four mem-
bers of the human 14-3-3 family fused to GST. All the 14-
3-3 isoforms that we have tested (β, η, σ, ζ) were able to
bind with comparable affinities to a POB1-GFP full-
length chimera over-expressed in HEK293 cells (Fig. 4A).
It should be noted that 14-3-3 proteins seem to enrich for
a slower migrating band, probably a phosphorylated form
of POB1.
In order to better define the POB1 region involved in the
interaction, we engineered a series of plasmids directing
the synthesis of deletion mutants of the POB1 protein:
POB1 126–252 contains the EH domain, POB1 308–365
encompasses the first poly-proline region, PRD1, POB1BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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The SH3 domains of Grb2 and Amphiphysin II bind the POB1 338PPTPPPRP345 peptide and the mutation R344A squelches the  interaction Figure 3
The SH3 domains of Grb2 and Amphiphysin II bind the POB1 338PPTPPPRP345 peptide and the mutation 
R344A squelches the interaction. A). The POB1 PRD1 (P308-V365) region was synthesized as 16 overlapping thirteen-
mers on a cellulose membrane. The membranes were probed with the SH3 domains of Amphiphysin II (AmphIISH3) or the 
carboxy-terminal SH3 of Grb2 (Grb2SH3-C) expressed in bacteria as GST fusions. GST alone is used as a negative control. 
Anti-GST antibodies were utilized to identify bound proteins. The peptide sequences are indicated. The best binding peptides 
are shown in bold. The three positive control peptides are: GST binding peptides (positive control for GST and secondary anti-
body) and two peptides containing SH3 interacting motifs. Each binding experiment was carried out in duplicate. The sequence 
in bold correspond to the best binders. The best peptide 338PPTPPPR344 shows an intensity above 11.000 arbitrary units. 
Another peptide containing the sequence 214LKARPS219 binds to the SH3 of Amphiphysin, albeit producing a spot intensity 
around 9000 arbitrary units. Quantitative data are available in additional file 3. B) The POB1 fifteenmer peptide 
(338PPTPPPRPQKTHSRA352), containing the 338PPTPPPR344 binding motif, was systematically mutagenized by introducing an 
alanine at each of the indicated 15 positions. The upper membrane was probed with GST as a control, the middle one with the 
SH3 domain of Amphiphysin II, the bottom one with the carboxy-terminal SH3 of Grb2 fused to GST. The substitution of 
arginine 344 with alanine reduces the binding of Amphiphysin-SH3 down to 2.5%; a substitution of proline 339 with alanine 
reduces the binding to 31%. A reduction in Grb2 binding is observed when arginine 344 is substituted with alanine (13%) and 
when Pro343 or Pro 435 are substituted with Ala (30%). Supplemental quantitative data are provided in additional file 4. C) 
HEK293 cells were transiently transfected with plasmids expressing GFP fused to the proline rich domain PRD1 of POB1 (lane 
1, 2, 3) or with an equivalent construct directing the synthesis of the POB1 PRD1 region mutated in Arg344 (PRD1 R344A), in 
lanes 4, 5, 6. Cell extracts were adsorbed to glutathione resins containing either the SH3 of Amphiphysin II (top gel) or the C-
terminal SH3 of Grb2 (bottom gel). Adsorbed proteins were identified with anti GFP antibodies (for POB1 PRD1). Input is 3% 
of the lysate utilized in the GST pull down.
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Different 14-3-3 isoforms bind to the PRD1 region of POB1 in a phospho-dependent manner Figure 4
Different 14-3-3 isoforms bind to the PRD1 region of POB1 in a phospho-dependent manner. A) Lysates of 
HEK293 cells, transiently transfected with POB1 fused to GFP, were incubated with four different isoforms of human 14-3-3 
fused to GST adsorbed to glutathione-sepharose 4B beads. The retained proteins were separated by SDS-PAGE and probed 
with anti-GFP antibody (for POB1). 5% of the extract used in the pull down was loaded in the input lane. B) HEK293 cells were 
transiently transfected with different POB1 deletion constructs fused to GFP: POB1 full length (1–521 amino acids), POB1 EH 
domain (126–252), POB1 proline rich region 1 PRD1 (308–365), POB1 pro-rich and carboxy-terminal (308–521) and POB1 
proline-rich region (308–398). Cell lysates were incubated with GST-14-3-3 ζ and GST alone, adsorbed to sepharose resin. 
The retained proteins were separated by 10% SDS-PAGE and probed with anti-GFP antibodies (for POB1). 5% of the extract 
adsorbed to the affinity resins was analyzed in the input lane. Figures in the deletion constructs refer to the amino acid residues 
of the POB1, short isoform, Swiss Prot entry Q8NFH8-2. The Ponceau staining shows the GST fusions and the input lysates. 
C). HEK293 cells were transiently transfected with vectors expressing GFP protein alone (panel above), POB1 PRD1 308–365 
(middle panel) or full length POB1 (below) fused to GFP and treated as in B. 50% of each cell lysate was incubated with the Ser/
Thr λ-phosphatase for 2 hours at 30°C before incubation with GST-14-3-3 ζ. Input lysates are 5% of the lysates adsorbed to 
the affinity resin. POB1 PRD1 and the full length POB1 are revealed by anti-GFP antibody. Upper panel is a negative control of 
mock vector expressing only GFP. D) A plasmid expressing Myc tagged POB1 was used to transfect HEK293 cells in two inde-
pendent replica experiments. Cells extracts expressing the empty plasmid (lane 1) or the Myc tagged POB1 (lanes 2 and 3) 
were immunoprecipitated with anti-Myc antibodies (for POB1). The proteins immunoprecipitated by anti-Myc (20% of the 
total lysate) were separated by SDS PAGE and probed with anti-14-3-3 (upper panel) or anti-Myc antibodies (second panel). In 
the upper panel, the endogenous 14-3-3 proteins co-immunoprecipitating with POB1 are revealed by anti-14-3-3. Also the 
slower migrating band of the longest 14-3-3 isoform, epsilon, is efficiently recovered. The control of the immunoprecipitated 
POB1 is shown in the second panel. The endogenous 14-3-3 proteins in the input lysate are revealed by anti-14-3-3 in the third 
panel where the slower migrating band of the longest 14-3-3 isoform epsilon is also visible (5% of total lysate). The ectopically 
expressed POB1-Myc is revealed with anti-Myc antibodies, in the bottom panel (1% of total lysate).BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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308–398 comprises two adjacent proline rich regions
while POB1 308–521 further extends to the carboxy-ter-
minal region including the RalBP1 binding domain (Fig-
ure 7). The pull down experiment in Figure 4B confirms
the interaction of 14-3-3 with the carboxy-terminal por-
tion of POB1 (from 308 to 521) and restricts the minimal
essential binding site to the PRD1 region of POB1 (resi-
dues 308 to 365) including both Ser322 and Ser354.
In order to assess whether POB1 binds to endogenous 14-
3-3, we transiently transfected HEK293 cells with Myc-
POB1 in two independent experimental repeats (Fig. 4D).
Cell lysates were immunoprecipitated with anti-Myc anti-
bodies (for POB1) while the co-immunoprecipitated
endogenous 14-3-3 proteins were detected with specific
antibodies. The results in Figure 4D, upper panel, show
that endogenous 14-3-3 proteins, including the largest
isoform (epsilon), co-immunoprecipitate with POB1.
Since most 14-3-3 interactions are phosphorylation
dependent [14-17]we tested whether the interaction
between 14-3-3 and POB1 PRD1 is mediated by a phos-
pho-peptide. We performed a pull down experiment as
described in Fig. 4B after incubating half of the cell extract
with λ-phosphatase, active towards phosphorylated serine
and threonine (Fig. 4C). When treated with phosphatase,
neither the full length POB1 (bottom panel, lane 4) nor
the POB1 PRD1 region (middle panel, lane 4) is effi-
ciently recovered by 14-3-3. The same absence of co-
immunoprecipitation occurred after wortmannin treat-
ment suggesting an involvement of Akt Ser/Thr kinase
(data not shown).
Taken together, these results suggest that the interaction
between POB1 and the 14-3-3 proteins can occur in vivo,
the recognized motif is encompassed in the region 308–
365 of POB1 and the binding is Ser/Thr phosphorylation
dependent.
Coimmunoprecipitation of POB1 with the isoform ζ is
observed also at endogenous levels in HeLa cells (Addi-
tional file 1).
Characterization of the 14-3-3 binding site: Ser354
As a means to map the 14-3-3 binding site, we have first
fragmented the POB1 PRD1 region (from residue 308 to
365) into fifteen amino acid long overlapping peptides
synthesized on a cellulose membrane (Fig. 5A, rows 2–8,
peptides 25–188). Since 14-3-3 proteins preferentially
bind motifs containing phosphorylated serines or thre-
onines, we have synthesized in parallel all of the PRD1
region's 15 mers containing a central serine or a threonine
(i.e., 36 peptides, from 193 to 228). These peptides were
synthesized both in the phosphorylated (row 9-and half
of row 10; labeled PRD pS/pT) and in the unphosphor-
ylated forms (half row 10- row 11; peptides 229–264,
labeled PRD). Fig. 5A shows the results obtained by prob-
ing the corresponding peptide array, with the human 14-
3-3 sigma isoform (Intensity diagram in Fig 5A and addi-
tional file 5 for quantitative data). Among the POB1 pep-
tides the one showing the strongest signal (indicated by a
black triangle, peptide No.202) is
347KTHSRASpSLDLNKVF361 (where pS represents phos-
phoserine 354), although its sequence does not match a
typical class 1 or class 2 14-3-3 consensus [14,15]. Similar
results were obtained by probing comparable membranes
with the zeta isoform (data not shown). This result iden-
tifies the phospho-Ser354 as an important determinant in
the 14-3-3 binding site and confirms the requirement for
a phosphorylated serine since the same peptide, in the un-
phosphorylated form, does not bind 14-3-3 (peptide No.
238). The second predicted 14-3-3 binding site, flanking
Ser322, binds 14-3-3 much less tightly when compared
with Ser354.
To confirm the functional relevance of the 14-3-3 binding
site characterized in vitro, we transiently co-transfected
HEK293 cells with 3xFLAG-14-3-3 isoform zeta and
POB1-GFP, bearing mutations in Ser354 and in Ser322.
The two serines are within two sequences resembling 14-
3-3 type 2 motifs (RSRS322YS and RASS354LD) and are pre-
dicted 14-3-3 ligands by the Motif Scan software at scan-
site.mit.edu. However, since the phospho-peptide
centered on Ser322 did not bind 14-3-3 in the membrane-
binding assay, we focused on the Ser354 motif by con-
structing Ser354Ala and Ser354Asp mutants. In addition,
we also constructed double mutants by mutating Ser 322
(Fig. 5B). Cell lysates were immunoprecipitated with anti-
FLAG antibodies (for 14-3-3) and the co-immunoprecipi-
tated POB1 was revealed with anti-GFP antibodies. As
shown in the upper panel (Fig. 5B), wild type POB1 co-
immunoprecipitates with 14-3-3 (lane 3), while, substi-
tuting Ser354 with Ala (lane 6) is sufficient to abolish
binding. Replacing Ser354 with a negatively charged resi-
due, aspartate, cannot mimic the 14-3-3 binding motif
(lane 5). These results prove that phosphorylation of
Ser354 in POB1 dictates 14-3-3 binding. The substitution
of Ser354 with aspartate does not recapitulate binding, as
often seen in 14-3-3 interactions with phosphorylated
substrates, as, for example, RGS or keratin [18,19]. These
data show that mutation of Ser354 in POB1 abolishes
interaction with 14-3-3.
Mutations affecting POB1 PRD1 binding to SH3 or 14-3-3 
suppress the dominant negative phenotype
To correlate binding to function, we decided to ask if the
expression of POB1 PRD1 mutated in the SH3 and the 14-
3-3 binding motifs is able to affect EGF induced receptor
endocytosis.BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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14-3-3 proteins bind a phospho-peptide centered on Ser354 Figure 5
14-3-3 proteins bind a phospho-peptide centered on Ser354. A) The sequence of POB1 was synthesized by the SPOT 
method in an array of 15 residue long peptides on a cellulose membrane. Numbers 1 to12 on the left of the membrane are the 
rows. Numbers on the right (24 to 280) are the numbers of the spotted peptides, reported in the intensity diagram. The first 
three intense spots in row 1 contain peptides RRFRsLPAAH, RRHRsAPGVR and RRSRsFPVTF (where 's' represents a phos-
phorylated serine) that serve as positive controls of 14-3-3 interactions. The peptides No. 25-188 (row 2–8) are 15 mers 
whose overlapping sequences span the POB1 sequence from Leu181 to the carboxy-terminal Leu521. Rows 9–11 contain 15 
mer-peptides whose sequence is centered on each single serine or threonine in the POB1 PRD1 (308–365). The peptides from 
No.193 to No. 228, in row 9 and the first 12 peptides in row 10, contain a centered phospho-serine or phospho-threonine. 
Their unphosphorylated counterparts, No. 229 to No. 264, occupy the last twelve spots in rows 10 and the 24 spots in row 
11. Row 12 contains positive and negative control peptides. The membrane was incubated with purified GST-14-3-3 sigma and 
probed with anti-GST antibodies. The control membrane, incubated with GST, was blank. The intensity of the interaction was 
revealed with a peroxidase coupled secondary antibody. The POB1 peptide showing the strongest signal (black triangle) is pep-
tide number 203, whose sequence 347KTHSRASsLDLNKVF361, is centered on phosphorylated Ser354 and shows a signal 
intensity of 8504 arbitrary units (a.u.), comparable with the strongest positive controls. Its non-phosphorylated counterpart is 
spot number 238 (intensity 991 a.u.). The peptide centered around Ser322 is No.196 (when phosphorylated) and shows a sig-
nal of 491 a.u., while its unmodified counterpart is No.232, 1400 a.u. A comparable result was obtained by probing the same 
array with GST-14-3-3 isoform zeta. The file reporting the quantitative analysis is in additional file 5. The graph is shown 
reporting the peptide number referred to the position on the membrane and the intensity measured. B) 3xFLAG 14-3-3 zeta 
was co-expressed in HEK293 with GFP or different constructs expressing POB1 full length-GFP wild type or bearing the indi-
cated mutations of Ser322 or/and Ser354 into alanine (A) or aspartate (D). Lane 1 and 2 are negative controls: in lane 1, the 
GFP empty vector was co-transfected with 14-3-3; in lane 2, POB1-GFP is co-transfected with the 3xFLAG empty vector. 
Upper blot: cell lysates were immunoprecipitated with anti-FLAG antibodies (for 14-3-3) and the co-immunoprecipitated 
POB1-GFP was revealed with anti-GFP antibodies. POB1-GFP is recovered only when Ser354 is not mutated. In the two gels 
below, 5% of the cell extract utilized in the immunoprecipitation was analyzed by gel electrophoresis and probed with anti-GFP 
(for POB1) antibodies or anti-FLAG (for 14-3-3) to assess POB1, GFP and 14-3-3 in input.
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Mutations in Ser354 or Arg344 abolish the dominant negative effect of POB1-PRD1 on EGF endocytosis Figure 6
Mutations in Ser354 or Arg344 abolish the dominant negative effect of POB1-PRD1 on EGF endocytosis. a) 
HeLa cells were transiently transfected with GFP-POB1 PRD1, GFP-POB1 or GFP-Dynamin K44, serum starved and incubated 
with TRITC-EGF for 20 minutes at 37°C. Cells were fixed and observed on an Olympus IX 70 with Nanomover® and soft-
WoRx DeltaVision. GFP transfected cells are visible in the 528 nm channel (green). TRITC EGF was visualized at 617 nm (fluo-
rescent spots). Nuclei were visualized by DAPI staining at 457 nm (blue). Transfected cells that do not show endocytic 
vescicles are indicated by a white arrow. b) HeLa cells were transiently transfected with GFP-POB1 PRD1 S354A or GFP-
POB1 PRD1 R344A and treated as above. Transfected cells are visible in the 528 nm channel as green cells. These cells show a 
wild type distribution of fluorescent endocytic vesicles (TRITC-EGF visualized at 617 nm). Nuclei were visualized by DAPI 
staining at 457 nm (blue). c) Overexpression of 14-3-3 abolish the dominant negative effect of POB1-PRD1 on EGF endocyto-
sis. HeLa cells were transiently transfected with GFP-POB1 PRD1 together with 3xFLAG-14-3-3 ζ. Cells were treated as 
above. Cells were then permeabilized and treated with Cy5-conjugated antibodies targeting the FLAG epitope of the 14-3-3 
proteins, visible at 685 nm. Cells were observed as described above. These cells show a wild type distribution of fluorescent 
endocytic vesicles (TRITC-EGF visualized at 617 nm).BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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In contrast with its wild type counterpart (Fig. 6A), the
over-expression of GFP-POB1 PRD1 S354A, mutated in
the serine residue that dictates 14-3-3 binding, does not
affect endocytosis. (Fig. 6B). Also, cells over expressing
POB1 PRD1 R344A, which is defective in binding to
Amphiphysin II and Grb2 SH3, do not show any interfer-
ence in the wild type EGF internalization (Fig. 6B). These
results demonstrate that the POB1 proline-rich region acts
as a dominant negative for EGF internalization and that
this negative effect can be rescued by mutations in the res-
idues that affect binding to 14-3-3 or to specific SH3.
Interestingly, the normal phenotype of endocytosis is
restored upon co-transfection of the wild type POB1
PRD1 region with 3xFLAG-14-3-3 ζ in over-expression
(Fig. 6C). We conclude that over-expression of 14-3-3 ζ
removes the endocytosis block caused by the dominant
negative effect of the PRD1 region of POB1.
Discussion
The observation that over-expression of the EH domain or
of the carboxy-terminal RalBP1 binding region of POB1/
REPS2 results in a 30–40% reduction of EGF or insulin
internalization has linked POB1 to the molecular machin-
ery modulating regulated endocytosis [4]. More recently,
it was reported that loss of POB1 expression during
human prostate cancer progression, from androgen-
dependent to growth factors dependent, results in loss of
control of cell growth signaling while induced expression
of POB1 causes a reduction of several EGF-responsive
genes (e.g., Fos and Jun). In accordance, we find that an
increase of POB1 isoform 2 expression correlates with a
decrease of EGF-induced phosphorylation of Erk1–2 and
Shc (Additional file 6). Moreover, POB1 isoform 2 down-
regulation was observed during the progression of pros-
tate cancer [7-9].
In our study we confirm the involvement of POB1 in EGF
receptor endocytosis and we provide evidence for a func-
tional role of the central proline-rich region. In fact, we
observed that over-expression of the proline-rich region of
POB1 (308–365) interferes with EGFR endocytosis while
leaving transferrin uptake unaffected (Fig. 1). This sug-
gests that, in addition to the N and C-terminal regions, the
central proline-rich domain (PRD1) of POB1, from
Pro308 to Val365, also plays an important function in reg-
ulated endocytosis and that over-expression of this por-
tion of POB1 disturbs the dynamics of protein
interactions by titration of elements required for regulated
endocytosis.
By panning phage displayed cDNA libraries, with a POB1
construct containing the proline-rich domain PRD1, we
enriched for phages displaying the carboxy-terminal SH3
domain of Grb2 and the SH3 domain of Amphiphysin II.
These in vitro identified physical interactions were further
confirmed in vivo, with full length POB1 (Fig. 2). A com-
plex between POB1 and Grb2 has already been reported
[6], We add that POB1 can bind Grb2 at endogenous lev-
els (Fig. 2 and Additional file 1) and we report that the
interaction occurs by means of the carboxy-terminal SH3
domain of Grb2. Interestingly the Grb2 binding motif in
POB1 (341PPPRP345) is exactly conserved in the Gab motif
(337PPPRPP342) that is also recognized by Grb2. This
motif is also conserved in the highly homologous human
protein REPS1. POB1 shows a punctate cytoplasmic local-
ization that is not much affected by EGF induction (Addi-
tional file 2). A substantial fraction of POB1 co-stains with
the late endosome markers CD63 or LAMP-1, as also
found for tyrosine-phosphorylated EGFR, Shc, Cbl and
Grb2 [20].
We describe Amphiphysin II as a new POB1 interactor.
POB1 cellular colocalization with clathrin is consistent
with this interaction, since Amphiphysin II is also a clath-
rin ligand (Additional file 2) (20). By alanine scanning
mutagenesis we have shown that both Grb2 and
Amphiphysin II SH3 bind to the same POB1 peptide,
however, different residues seem to be the main determi-
nants of recognition specificity. Amphiphysin II binding
is affected by changes in Arg344 and Pro339 while Grb2
binding is sensitive to changes in Pro342 and Pro 345
(Fig. 3).
We have characterized a second linear motif of POB1 con-
taining a phosphorylated serine and mediating binding to
the 14-3-3 isoforms (Fig. 4). This binding site was
mapped approximately ten amino acids away from the
SH3 binding motif (Fig. 5). 14-3-3 binding was shown to
be sensitive to phosphatase treatment (Fig. 4) and binding
was abolished when Ser354 was mutated to Ala or to Asp
(Fig. 5). This suggests that POB1 binds 14-3-3 in a phos-
phorylated form. Significantly, the characterized POB1
peptide sequence HSRASsLDLNK, only displays poor sim-
ilarity to the classical 14-3-3 binding motifs [15]. In fact,
while presenting the conserved Arg at position -3 from the
phosphorylated serine, it displays a few uncommon fea-
tures, such as an Asp at position +2, in place of the pre-
ferred Pro. This divergence is not anomalous, given that
physiological substrates often bind 14-3-3 through pep-
tide ligands which do not exactly match the most com-
mon motifs [21]. Interestingly binding is abolished if
Ser353, immediately preceding the phosphorylated
Ser354, is also phosphorylated (data not shown). 14-3-3
have been described as forming complexes with more
than 200 partners in high throughput studies and poten-
tially engaging 0.6% of the human proteome [22]. Some
of these complexes have been implicated in regulating
protein membrane trafficking. For instance, 14-3-3 were
shown to reduce endoplasmic reticulum (ER) localiza-BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
Page 12 of 18
(page number not for citation purposes)
tion, thereby promoting surface expression of membrane
proteins [17,23].
It has to be emphasized that 14-3-3 zeta has already been
reported as associating with the epidermal growth factor
receptor cytoplasmic tail and co-localizing along the
plasma membrane with EGFR upon EGF stimulation [24].
Thus a 14-3-3 dimer could bridge POB1 to the EGFR upon
EGF induction. Similarly, 14-3-3 proteins appear to be the
essential molecular bridge between the alfa1-subunit of
the Na+, K+, -ATPase in the plasma membrane and the PI
3-kinase, thus providing the signal to initiate endocytosis
of the protein in response to natriuretic hormones [25].
Finally 14-3-3 sigma is phosphorylated in prostate cells in
response to EGF [26]. It is interesting to note that the 14-
3-3 binding motif HSRxSSLD flanking Ser354 of POB1,
that we find essential for interaction with 14-3-3, is con-
served in the mouse orthologs and flanks the Ser510 of
human REPS1, that is found phosphorylated in vivo in
A431 cells (Stover DR et al. Phosphosite: http://
www.phosphosite.org). This serine site is predicted to be
phosphorylated by Akt or calcium/calmodulin-dependent
protein kinase II gamma, CaMK2G. In agreement, we
observed absence of 14-3-3-coimmunoprecipitated POB1
when cells where treated with phosphatase or wortman-
nin (not shown), an inhibitor of PI3K and consequently
of Akt.
To further test the model we assayed the POB1 proline-
rich construct harboring the point mutation R344A,
which prevents binding of Grb2 and Amphiphysin II and,
as expected, we did not observe the dominant negative
effect on EGFR internalization (Fig. 6). Thus, the
Arg344Ala mutation both affects the formation of the
POB1/Grb2 and POB1/Amphiphysin II complexes and
also abolishes the dominant negative phenotype affecting
endocytosis. This suggests that titration of either SH3 con-
taining partner affects EGFR internalization. Similarly, a
POB1 PRD1 construct whose ability to bind 14-3-3 was
impaired by a Ser354Ala mutation, was unable to inhibit
endocytosis in over-expression conditions (Fig. 6). In
addition, we have found that co-expression of 14-3-3
relieves the dominant negative effect of POB1-PRD1 on
EGFR internalization (Fig. 6). Mechanistically, 14-3-3 ζ
could offset the negative POB1-PRD1 over-expression
effect, by binding POB1-PRD1 and by preventing the
recruitment and trapping of a second essential physiolog-
ical ligand.
Conclusion
We confirm that POB1 plays an active role in controlling
the dynamics of ligand-dependent receptor internaliza-
tion and signaling. This is mediated by several interac-
tions with diverse protein partners [4,5]. In this work, we
provide evidence of the central role played by the proline
rich region of POB1 through binding to 14-3-3 and to the
SH3 of Grb2 and Amphyphisin II (Fig. 7). We observe that
these interactions are not EGF dependent and are proba-
bly exclusive, since the binding motifs are only nine
amino acid apart.
The artificial over-expression of this portion of POB1
affects endocytosis by titration of essential components,
leading to formation of partial complexes that are not
functional [7]. Thus POB1 acts as a sort of scaffold to enu-
cleate a complex that is required for receptor internaliza-
tion. The assembly and composition of this complex is
finely regulated by protein concentration. Besides contrib-
uting to expanding and further characterizing the func-
tional endocytosis "interactome", these results add to the
molecular interpretation of POB1 as a tumor suppressor,
due to its acting as a scaffold to bridge proteins which are
established promoters of endocytosis and, subsequently,
of receptor down regulation.
Methods
Cell culture and transient transfection
HeLa and human embryonic kidney cell line HEK293
Phoenix were grown at 37°C in a 5% CO2 incubator, in
DMEM (Gibco/Invitrogen) supplemented with 10% fetal
bovine serum (SIGMA-Aldrich), penicillin and streptomy-
cin (Gibco). HeLa cells were transfected with Lipo-
fectamine 2000 reagent (Invitrogen) following
manufacturer's instructions while HEK293 cells were
transfected with the calcium-phosphate method.
Plasmids
The plasmid vectors encoding for GFP-POB1, GFP-
Dynamin K44A and FLAG-Amphiphysin II were a gener-
ous gift from A. Kikuchi, G. Cestra and H. Daub, respec-
tively. The remaining plasmids were constructed by
standard recombinant DNA techniques. Briefly, the cDNA
encoding for the Amphiphysin II Src homology 3 domain
(SH3) was cloned using SalI and BglII pYEX (modified
pGEX-2TK, Amersham) unique sites, and GST-Grb2 car-
boxy-terminal SH3 was generated by cloning the corre-
sponding cDNA in pYEX BamHI and NotI sites. The
construct expressing GST-POB PRD1 was generated by
amplifying the corresponding POB1 cDNA region and
cloning it into BamHI and EcoRI pYEX unique sites. The
same POB1 cDNA region (POB1/REPS2 Swiss-prot:
Q8NFH8, isoform 2, 521 amino acids) was cloned into
the BglII and EcoRI sites of pEGFP-C1 vector (BD Bio-
science Clontech) for expression in eukaryotic cells. PRD1
region was amplified by PCR with the primers 5'-ATC-
CAGGATCCCCCAAGGATTCCAACAGT-3' and 5'-TGGT-
GAATTCCACACTGGGCTGGAAGAC-3' and sub cloned
into  BglII and EcoRI sites; the PRD1–PRD2 (308–398)
fragment was amplified by PCR with the oligos 5'ATC-
CAGGATCCCCCAAGGATTCCAACAGT-3' andBMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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5'GGCAAGCTTTTACACTTGTTCAGACTGTGA-3' and
cloned into the BglII-HindIII sites; the NH2 terminal-EH
region was amplified by PCR with the oligos 5'TGCCT-
GGATCCATGATGTCAAAGAAT-3' and 5'GATGAAT-
TCGCTGCAGAGTTGGAGGGAGGC and subcloned into
the BglII-EcoRI sites; the PRO-RICH and carboxyterminal
region (308–521) was amplified by PCR with oligos:
5'ATCCAGGATCCCCCAAGGATTCCAACAGT-3' and
5'TGTCTAGACAACACAGTGACCGGACG-3' and cloned
into the BglII-SalI sites. Site-directed mutagenesis of GFP-
POB PRD1 to obtain GFP-POB1 PRD1 R344A was carried
out by assembly of two overlapping DNA fragments
obtained by PCR amplification with pairs of complemen-
tary primers (R1299 5'ACCCCGCCACCTGCACCACA-
GAAAACC-3', R1300
5'GGTTTTCTGTGGTGCAGGTGGCGGGGT-3'), each car-
rying the mutated sequence, and two oligos priming from
the 5'- and 3'-ends of the wild type POB1 proline-rich
sequence. This latter pair of primers contained the BamHI
and EcoRI sites for cloning into the pEGFP-C1 vector. The
Outline of POB1/REPS2 and synopsis of its protein interactions Figure 7
Outline of POB1/REPS2 and synopsis of its protein interactions. POB1/REPS2 isoform 2 is represented as a line of 521 
residues. The EH domain is from 127 to 226; the central proline-rich region is 308–398; the carboxy-terminal part is a coiled-
coil. Evidences presented in this work support interactions involving the first proline rich domain 308–365 (PRD1). The SH3 of 
Amphiphysin II and the carboxy-terminal SH3 of Grb2 specifically bind a peptide centered around arginine 344, while the 14-3-
3 family proteins bind the serine 354, if phosphorylated. The proteins recognized by the EH domain of POB1 are: Epsin [5], Nf-
kB [9] and Eps15 [28,4]. The proteins interacting with the distal proline rich domain and the C-terminal domain are RalBP1 (1), 
and DDEF1/PAG2/ASAP1 whose SH3 domains bind a peptide including P423 and P425 [6]. The phosphorylation of Ser411 by 
p34 (cdc2) in mitotic phase [29] is reported, the phosphorylation of Ser354 is discussed in this work. The box below shows the 
consensus sequence for 14-3-3 and SH3 binding in the POB1 human paralogs and mouse orthologs: human REPS1 Q96D71, 
mouse REPS1 O54916 and mouse REPS2 Q8OXA6. The POB1 sequence coordinates refer to human REPS2 Q8NFH8-2.BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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cDNA encoding for POB1 was cloned into pcDNA3.1/
Myc-His EcoRI and NotI unique sites. Finally, HA-Grb2
was constructed by amplifying the cDNA coding for Grb2
and cloning it into BglII and EcoRI sites of pcDNA-HA
(Natoli et al., 1997).
The plasmid vectors pFLAG CMV2 encoding the 14-3-3
isoforms  β,ε,η,θ,σ,ζ were a generous gift from Takashi
Tsuruo. The same isoforms were subcloned in a pCDNA/
FRT/TO Invitrogen modified by insertion of a box encod-
ing a 3xFLAG tag and a cloning site suitable for the LIC
cloning method (52), flanked by HindIII-BamHI sites. The
3xFLAG box was inserted utilizing the oligos:
5'CCCAAGCTTACCATGGACTACAAAGACCAT-3' and
5'CGGGATCCCCGTTATCCACTTTCCCCGGGGGATT-
GGAAGTACAGCTTGTCATCGTCATC-3'. The 14-3-3 iso-
forms were amplified by PCR and cloned in this box using
the oligos:
5'TACTTCCAATCCCCCGGCATGACAATGGATAAAAGT
and
5'TTATCCACTTTCCCCGTTAGTTCTCTCCCTCCCC for β;
5'TACTTCCAATCCCCCGGCATGGATAAAAATGAGCT-
GGTT and
5'TTATCCACTTTCCCCGTTAATTTTCCCCTCCTTCTC for
ζ;
5'TACTTCCAATCCCCCGGCATGGATGATCGAGAG-
GATCT and
5'TTATCCACTTTCCCCGTCACTGATTTTCGTCTTCCA for
ε;
5'TACTTCCAATCCCCCGGCATGGGGGACCGGGAG-
CAGC and
5'TTATCCACTTTCCCCGTCAGTTGCCTTCTCCTGCTT for
η;
5'TACTTCCAATCCCCCGGCATGGAGAGAGCCAGTCT-
GATC and
5'TTATCCACTTTCCCCGTCAGCTCTGGGGCTCCTGGG
for σ. The cDNA encoding for GST 14-3-3 β,ε,η,θ,σ,ζ was
cloned into the LIC site of a pGEX-2T-K modified by inser-
tion of a box suitable for LIC cloning method in BamHI
and EcoRI sites, by the annealed oligos
5'GATCCCTGTACTTCCAATCCCCCGGGGAAAGTGGA-
TAACGGG-3' and
5'AATTCCCGTTATCCACTTTCCCCGGGGGATTGGAAG-
TACAGG.
Site directed mutagenesis of GFP-POB1 and GFP-POB1-
PRD1 to obtain GFP-POB1 S354A, GFP-POB1 S322A,
GFP-POB1 S322/354A and GFP-POB1 PRD1 S354A was
carried out by using the QuikChange Site-directed Muta-
genesis Kit (Stratagene) with primers R1528 for S354D:
5'ACCCATTCCAGAGCCTCCGACTTGGATCTGAATAAA;
R1529 for S322A:
5'GCAAGACCAAGATCCAGAGCTTACTCTAGCACC;
R1530 for S322D:
5'GCAAGACCAAGATCCAGAGATTACTCTAGCACC;
R1532 for S354A:
5'ACCCATTCCAGAGCCTCCGCCTTGGATCTGAATAAA.
It should be noted that all the residue numbering of
POB1/REPS2 refers to the isoform 2, Q8NFH8-2.
Antibodies
The antibodies used in these experiments were a mouse
monoclonal anti-T7 (Novagen), a rabbit polyclonal anti-
lambda serum, a mouse monoclonal anti-HA (SIGMA-
Aldrich), a mouse monoclonal anti-FLAG (SIGMA-
Aldrich), a rabbit polyclonal anti-GFP (Santa Cruz), a
mouse monoclonal anti-Grb2, a mouse monoclonal anti-
CHC, a mouse monoclonal anti-EEA1, a mouse mono-
clonal anti-CD63, a mouse monoclonal anti-Lamp2, a
mouse monoclonal anti-GM130 (all from Becton Dickin-
son Transduction Laboratories); rabbit anti 14-3-3 zeta
(Santa Cruz); a mouse monoclonal anti 14-3-3 sigma
(Santa Cruz); mouse monoclonal anti 14-3-3 (Neomar-
ker); polyclonal anti-REPS2 raised in rabbit (Atlas Anti-
body). A rabbit polyclonal anti-POB1 serum was
generated against a N-terminal part of POB1, tested on
western blot in parallel with commercial anti-REPS2. Sec-
ondary antibodies used in this work were an alkaline
phosphatase-conjugated anti-rabbit IgG, an alkaline
phosphatase-conjugated anti-mouse IgG (both from
SIGMA-Aldrich), a peroxidase-conjugated anti-mouse and
anti-rabbit IgG, a Rhodamine Red-X-coupled anti-rabbit
(all from Jackson ImmunoResearch). Cy5-coupled anti
mouse (from Jackson ImmunoResearch) and an Alexa
Fluor 488-coupled anti-mouse (Molecular Probes).
Pull-down experiments
GST and GST-fusion proteins (100 μg) expressed in bacte-
ria and adsorbed to glutathione-sepharose 4B beads
(Amersham) were incubated for two hours at 4°C with 1
mg of HEK293 cellular extract in JS lysis buffer (50 mM
Hepes, 150 mM NaCl, 1% Glycerol, 1% Triton-X100, 1.5
mM MgCl2, 5 mM EGTA, 1 mM PMSF, 10 μg/ml Leupep-
tin, 10 μg/ml Aprotinin, 1 μM NaVO4). Beads wereBMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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washed three times in ice-cold PBS. Bound proteins were
electrophoresed on a 10% polyacrylamide gel, transferred
onto nitrocellulose membranes and detected with specific
antibodies.
Protein dephosphorylation
To release phosphate groups from serine or threonines,
cell lysis was performed by adding JS buffer without phos-
phatase inhibitor (50 mM Hepes, 150 mM NaCl, 1%
Glycerol, 1% Triton X-100, 1.5 mM MgCl2, 5 mM EGTA,
protease inhibitor cocktail Sigma-Aldrich 200×). The cell
extracts were incubated with 300 units of phosphoSer/Thr
λ protein phosphatase (for 500 micrograms of total pro-
tein extract) for 2 h at 30°C. Otherwise, to inhibit Akt Ser/
Thr kinase, cells were serum-starved for 4 hours and incu-
bated with 200 nM wortmannin in Dimethyl-Sulfoxide
(DMSO) for 30 minutes at 37°C. Controls were carried
out in similar conditions in the absence of λ phosphatase
or in DMSO without wortmannin.
Co-immunoprecipitation
Transfected HEK293 cells were washed in ice-cold PBS
and lysed in ice-cold JS buffer (50 mM Hepes, 150 mM
NaCl, 1% Glycerol, 1% Triton-X100, 1.5 mM MgCl2, 5
mM EGTA, 1 mM PMSF, 10 μg/ml Leupeptin, 10 μg/ml
Aprotinin, 1 μM NaVO4). Cellular extracts were incubated
with anti-FLAG M2 affinity gel (SIGMA-Aldrich) or with
anti-HA antibody for 2 hours at 4°C. After incubation the
affinity resins were washed three times in NET buffer (50
mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Triton X-100,
1 mM EDTA, 1 mM PMSF, 10 μg/ml Leupeptin, 10 μg/ml
Aprotinin, 1 mM NaVO4) and the adsorbed proteins ana-
lyzed by electrophoresis on a 10% polyacrylamide gel,
transferred onto nitrocellulose membranes and revealed
with specific antibodies.
Immunofluorescence
HeLa cells were grown on glass cover slips, serum-starved
for 4 hours and incubated with 100 ng/ml of EGF for 20
minutes at 37°C and 5% CO2. Cells were cooled on ice,
washed three times in ice-cold PBS, then fixed in 4% para-
formaldehyde (SIGMA-Aldrich) for 30 minutes at room
temperature and washed in 0.1 M glycine in PBS. Cells
were made permeable with 0.1% Triton X-100 for 5 min-
utes and incubated in blocking solution (10% FBS in PBS)
for 40 minutes. HeLa cells were incubated over-night at
4°C with primary antibodies diluted in blocking solution,
washed three times in PBS and incubated with secondary
antibodies coupled to different fluorochromes (Alexa
Fluor 488-coupled anti-mouse from Molecular Probes
and Rhodamine Red-X-coupled anti-rabbit from Jackson
Immuno-Research) for 1 hour at 37°C.
After washing in PBS, coverslips were mounted in Prolong
Antifade (Molecular Probes) and images were acquired on
a confocal microscope (Leica TCS SP2) or on Olympus IX
70 with Nanomover® and softWoRx DeltaVision (Applied
Precision) with a U-PLAN-APO 100× objective.
For assaying endocytosis, HeLa cells were grown on cover-
slips and transiently transfected with various cDNAs. After
24 hours from transfection cells were serum-starved for 4
hours, then incubated with TRITC-EGF (2 μg/ml) or
TRITC-Transferrin (100 μg/ml) (Molecular Probes) for 20
minutes at 37°C and 5% CO2. Internalization of the fluo-
rescence signal was monitored as described above. Nuclei
were stained with Hoechst 33258 or 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI).
Spot synthesis
Cellulose membrane-bound peptides were automatically
synthesized according to standard SPOT synthesis proto-
cols [27] using a Spot synthesizer MultiPep Spotter
(Intavis AG, Germany). To limit background signals, all
cysteines were replaced by serines. The generated arrays of
peptides were synthesized on Amino-PEG500-UC540
Sheet (acid hardened) (Intavis AG, Germany). The mem-
brane, was activated in Ethanol (3 times for 10 minutes),
washed 3 times in PBS, blocked in PBS/BSA 5% and then
incubated with Glutathione S-Transferase (GST) fusion
proteins (10 micrograms/ml) in PBS/BSA 5% Incubation
with GST alone at the same concentration in the same
buffer is used as negative control. The membrane was then
treated with anti GST antibody and finally with peroxi-
dase labeled anti goat antibody. Chemiluminescent sig-
nals were acquired with a LAS3000 instrument (FujiFilm)
and analyzed with the software AIDA.
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Additional material
Additional file 1
Co-immunoprecipitation of POB1 with Grb2 and 14-3-3 at endog-
enous level is not EGF dependent. HeLa cells were starved for 4 hours in 
serum deprived medium and induced by addition of EGF at 100 ng/ml, 
when indicated. Cells were lysed and treated as described. Protein lysates 
were immunoprecipitated with anti-POB1 (lane 2,3) and mock antibody 
in lane 1. The co-immunoprecipitated proteins were separated on SDS-
PAGE, transfered onto nitrocellulose membranes and probed with anti-
Grb2 or anti-14-3-3 zeta. Input is 5% of the amount loaded in the lanes 
of co-immunoprecipitations.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-21-S1.tiff]
Additional file 2
POB1 localization in different sub cellular compartments: Localiza-
tion is not EGF dependent. HeLa cells were stained with anti-POB1 
antibodies together with antibodies for markers of specific cellular struc-
tures: anti-clathrin CHC (staining coated pits), anti-EEA1 (early endo-
somes), anti-CD63 (late endosomes), anti-GM130 (Golgi), and anti-
LAMP2 (lysosomes) Secondary antibodies were: Alexa-Fluor 488-coupled 
anti mouse, to stain the cell structure markers (green) and Rhodamine-
conjugated anti rabbit, to stain POB1 (red). Images were acquired on 
Olympus IX 70 with Nanomover® and softWoRx DeltaVision. In "merge", 
a yellow color indicates co localization. In panel A, HeLa were not treated 
with EGF. In panel B HeLa were treated with EGF 100 ng/ml.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-21-S2.tiff]
Additional file 3
POB1 scanning: SH3 binding. This file provides additional data to Fig. 
3A. Scanning of the POB1 proline-rich from Pro308 to Val365, with the 
SH3 domain of Amphihphysin II (No 2-38), Grb2 carboxy-terminal SH3 
(No. 39-76) and GST (No.77-114) as negative control. The sequence of 
the peptides is reported. Signal intensity of binding is reported in column 
labeled QL, as arbitrary units. Best binders are shown in red.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-21-S3.xls]
Additional file 4
POB1 338–352 Alanine scanning. Additional data to Fig. 3B. Alanine 
Scanning Mutagenesis of the region POB1 338-PPTPPPRPQKTHSRA-
352. The mutagenized peptides are indicated in the first column. The sig-
nal intensity obtained by probing with each SH3 domain or the GST alone 
is reported in second column. The intensity belonging to mutagenized pep-
tides that have lost binding are in red.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-21-S4.xls]
Additional file 5
POB1 scanning: 14-3-3 binding. Additional data to Fig. 5A. The first 
three spot positions are positive control peptides. From spot No. 25 to No. 
188 (row 2–8) are the POB1 peptides obtained by scanning the POB1 
sequence from L181 to L521. From spot No. 193 to No. 228 are the pep-
tides containing a phosphorylated serine or threonine in the eighth posi-
tion, as indicated by a s/t. From No. 229 to No. 264 are the same peptides 
as above but bearing an unphosphorylated Ser or Threo, indicated by S/T. 
From No. 265 to No. 280 are controls. The peptides were challenged with 
14-3-3 sigma fused to GST. Intensity is reported in arbitrary units.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2091-9-21-S5.xls]BMC Biochemistry 2008, 9:21 http://www.biomedcentral.com/1471-2091/9/21
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and the empty vector, encoding GFP, as a negative control. After 24 hours, 
cells were starved for 16 hours in serum deprived medium and induced by 
addition of Epidermal Growth factor (EGF) at 100 ng/ml final concen-
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or 5 minutes. Phosphorylated and input proteins were normalized. Fig. 5. 
EGF induction control. Cellule HEK293 Phoenix, Hela and A431 were 
serum starved for 16 hours (lane 1,3,5) and stimulated by EGF (100 ng/
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probed with anti-phosphotyrosine antibody 4G10.
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